Recognition, diagnosis, and treatment of primary focal hyperhidrosis - 24/08/11

Doi : 10.1016/j.jaad.2003.12.029

John Hornberger, MD, MS ^a,^b,^⁎ , Kevin Grimes, MD ^a, Markus Naumann, MD ^c, Dee Anna Glaser, MD ^d, Nicholas J Lowe, MD ^e, Hans Naver, MD, PhD ^f, Samuel Ahn, MD ^g, Lewis P Stolman, MD ^h
From the Stanford University School of Medicine,^a Acumen, LLC,^b University of Würzberg,^c St. Louis University Medical Center,^d Cranley Clinic for Dermatology,^e Uppsala University Hospital,^f UCLA Medical Center,^g and the University of Medicine and Dentistry of New Jersey—New Jersey Medical School.^h USA

Reprint requests: John Hornberger, MD MS, 1415 Rollins Rd, Suite 110, Burlingame, CA 94010.

on behalf of the Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis Stanford and Los Angeles, California; St. Louis, Missouri; Newark, New Jersey; London, England; Würzberg, Germany; and Uppsala, Sweden

Plan

Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis: Chair: John Hornberger, MD, MS, Stanford University School of Medicine, Stanford, Calif and Acumen, LLC, Burlingame, Calif; Co-Chair: Kevin Grimes, MD, Stanford University School of Medicine, Stanford, Calif; Samuel S. Ahn, MD, UCLA Medical Center, Los Angeles, Calif; Sten-Magnus Aquilonius, MD, Uppsala University Hospital, Uppsala, Sweden; Daniel Berg, MD, University of Washington Medical Center, Seattle, Wash; Timothy G. Berger, MD, UCSF Medical Center, San Francisco, Calif; Cliff P. Connery, MD, FACS, Columbia University College of Physicians and Surgeons, New York, NY; Jonathan R. Davidson, MD, Duke University Medical Center, Durham, NC; Dee Anna Glaser, MD, St. Louis University Medical Center, St. Louis, Mo; Henning Hamm, MD, University of Würzberg, Würzberg, Germany; Marc Heckmann, MD, Ludwig-Maximilian University, Munich, Germany, Adelaide A. Herbert, MD, University of Texas at Houston Health Science Center, Houston, Tex; Horatio C. Kaufmann, MD, Mount Sinai Medical Center New York, NY; John Koo, MD, UCSF Medical Center, San Francisco, Calif; Louis Kuchnir, MD, PhD, University of Massachusetts, Amherst, Mass; Mark Lebwohl, MD, Mount Sinai School Hospital, New York, NY; Nicholas J. Lowe, MD, Cranley Clinic for Dermatology, London, England; Alan Menter, MD, Texas Dermatology Associates, P.A. Dallas, Tex; Markus Naumann, MD, University of Würzberg, Würzberg, Germany; Hans Naver, MD, PhD, Uppsala University Hospital, Uppsala, Sweden; Ib Odderson, MD, Overlake Hospital and Medical Center, Bellevue, Wash; David M. Pariser, MD, Eastern Virginia Medical School, Norfolk, Va; Frederick A. Pereira, MD, New York Presbyterian Hospital of Queens, New York, NY; Lewis P. Stolman, MD, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, NJ; Carl F. Swartling, MD, Uppsala University Hospital, Uppsala, Sweden; Ada Regina Trinidade de Almeida, MD, Hospital do Servidor Público Municipal São Paulo, São Paulo, Brazil.
Disclaimer: Adherence to the recommendations in this manuscript will not ensure successful treatment in every situation. Furthermore, these recommendations should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific therapy must be made by the physician and the patient considering all the circumstances presented by the individual patient.
Funding sources: Allergan provided financial support for (1) search, synthesis, and analysis of the literature, (2) meeting of the working group to develop this manuscript, and (3) preparation of the manuscript. The sponsor had no role in the analyses or interpretation of the results. All authors had unlimited access to the literature and its analyses. No limitations on publication were imposed, and review before final publication was not required. The authors made final decisions on all aspects of the manuscript.
Conflicts of interest: (1) Each author received honoraria for attending and participating in the consensus statement development process. (2) With the exception of the Chair and Co-Chair of this committee, committee members are employed or derive income from the practice of medicine involving consultation or use of procedures to manage patients with hyperhidrosis. (3) Dr. Hornberger is Clinical Professor of Medicine at Stanford University School of Medicine, and derives no clinical income.